Возможности определения генетических полиморфизмов гена аполипопротеина е для прогнозирования эффективности и безопасности противовирусной терапии пациентов с хроническим вирусным гепатитом с
О Л Лобанова, В В Рафальский, Михаил Михайлович Храмцов et al. · Биомедицина · 2011
To investigate the possibility to use the identification of genetic polymorphisms of apolipoprotein E (ApoE) gene in patients with chronic HCV infections for prediction of efficacy and safety of antiviral therapy. Weight loss during antiviral therapy appeared more often in patients with ApoE (2/3) and nave in patients with genotype of ApoE (3/3). During antiviral therapy allergic dermatitis and thrombocytopenia develop more often in patients with ApoE (2/3).
Cited by 0 works.